{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:01:57Z","timestamp":1777330917989,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s11886-017-0888-0","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T10:25:31Z","timestamp":1501151131000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk"],"prefix":"10.1007","volume":"19","author":[{"given":"Joshua I.","family":"Barzilay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara L.","family":"Pressel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alokananda","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Puttnam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul K.","family":"Whelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"issue":"2","key":"888_CR1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.290.2.199","volume":"290","author":"I Hajjar","year":"2003","unstructured":"Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290(2):199\u2013206.","journal-title":"JAMA"},{"issue":"9","key":"888_CR2","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/j.1532-5415.2004.52420.x","volume":"52","author":"SL Silverman","year":"2004","unstructured":"Silverman SL, Delmas PD, Kulkarni PM, Stock JL, Wong M, Plouffe L Jr. Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis. J Am Geriatr Soc. 2004;52(9):1543\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"888_CR3","first-page":"19","volume":"5","author":"GN Farhat","year":"2008","unstructured":"\u2022 Farhat GN, Cauley JA. The link between osteoporosis and cardiovascular disease. Clin Cases Miner Bone Metab. 2008;5(1):19\u201334. This study reviews most of the studies that find a link between cardiovascular disease and osteoporosis and fractures. It describes possible mechanisms to explain these associations.","journal-title":"Clin Cases Miner Bone Metab"},{"key":"888_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/bonekey.2012.144","volume":"1","author":"P Szulc","year":"2012","unstructured":"\u2022 Szulc P. Association between cardiovascular diseases and osteoporosis \u2013 reappraisal. Bonekey Rep. 2012;1:144. doi:\n10.1038\/bonekey.2012.144\n\n. A very good summary of studies describing the association of cardiovascular disease with bone disease.","journal-title":"Bonekey Rep"},{"issue":"6","key":"888_CR5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/ckj\/sfv104","volume":"8","author":"M Cozzolino","year":"2015","unstructured":"Cozzolino M, Pasquali M. Where is the link between mineral bone markers and cardiovascular disease in CKD? Clin Kidney J. 2015;8(6):729\u201331.","journal-title":"Clin Kidney J"},{"issue":"11","key":"888_CR6","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1007\/s00198-016-3649-9","volume":"27","author":"JI Barzilay","year":"2016","unstructured":"Barzilay JI, B\u016f\u017ekov\u00e1 P, Fink HA, Cauley JA, Robbins JA, Garimella PS, et al. Systemic markers of microvascular disease and bone mineral density in older adults: the cardiovascular health study. Osteoporos Int. 2016;27(11):3217\u201325.","journal-title":"Osteoporos Int"},{"issue":"11","key":"888_CR7","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2014-2409","volume":"99","author":"P B\u016f\u017ekov\u00e1","year":"2014","unstructured":"B\u016f\u017ekov\u00e1 P, Barzilay JI, Fink HA, Robbins JA, Cauley JA, Fitzpatrick AL. Ratio of urine albumin to creatinine attenuates the association of dementia with hip fracture risk. J Clin Endocrinol Metab. 2014;99(11):4116\u201323.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9183","key":"888_CR8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(99)01437-3","volume":"354","author":"FP Cappuccio","year":"1999","unstructured":"Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of osteoporotic fractures research group. Lancet. 1999;354(9183):971\u20135.","journal-title":"Lancet"},{"issue":"2","key":"888_CR9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00223-008-9198-2","volume":"84","author":"P Vestergaard","year":"2009","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L. Hypertension is a risk factor for fractures. Calcif Tissue Int. 2009;84(2):103\u201311.","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"888_CR10","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00198-007-0386-0","volume":"18","author":"U Sennerby","year":"2007","unstructured":"Sennerby U, Farahmand B, Ahlbom A, Ljunghall S, Micha\u00eblsson K. Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int. 2007;18(10):1355\u201362.","journal-title":"Osteoporos Int"},{"issue":"1","key":"888_CR11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00198-013-2457-8","volume":"25","author":"S Yang","year":"2014","unstructured":"\u2022 Yang S, Nguyen ND, Center JR, Eisman JA, Nguyen TV. Association between hypertension and fragility fracture: a longitudinal study. Osteoporos Int. 2014;25(1):97\u2013103. A fine review of the association of hypertension with bone disease.","journal-title":"Osteoporos Int"},{"issue":"4","key":"888_CR12","first-page":"624","volume":"120","author":"EW Young","year":"1992","unstructured":"Young EW, Morris CD, McCarron DA. Urinary calcium excretion in essential hypertension. J Lab Clin Med. 1992;120(4):624\u201332.","journal-title":"J Lab Clin Med"},{"key":"888_CR13","doi-asserted-by":"crossref","unstructured":"Grobbee DE, Hackeng WHL, Birkenhager JC, Hofman A. Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure. Br Med J. 1988;296(6625):814\u20136.","DOI":"10.1136\/bmj.296.6625.814"},{"key":"888_CR14","doi-asserted-by":"crossref","unstructured":"McCarron DA. Low serum concentrations of ionized calcium in patients with hypertension. N Engl J Med. 1982;307(4):226\u20138.","DOI":"10.1056\/NEJM198207223070405"},{"issue":"4","key":"888_CR15","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/HYPERTENSIONAHA.111.186833","volume":"59","author":"FM Abboud","year":"2012","unstructured":"Abboud FM, Harwani SC, Chapleau MW. Autonomic neural regulation of the immune system: implications for hypertension and cardiovascular disease. Hypertension. 2012;59(4):755\u201362.","journal-title":"Hypertension"},{"issue":"1\u20133","key":"888_CR16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12026-014-8548-6","volume":"59","author":"MV Singh","year":"2014","unstructured":"Singh MV, Chapleau MW, Harwani SC, Abboud FM. The immune system and hypertension. Immunol Res. 2014;59(1\u20133):243\u201353.","journal-title":"Immunol Res"},{"issue":"3","key":"888_CR17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/jcp.21564","volume":"217","author":"N Bonnet","year":"2008","unstructured":"Bonnet N, Benhamou CL, Malaval L, Goncalves C, Vico L, Eder V, et al. Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions. J Cell Physiol. 2008;217(3):819\u201327.","journal-title":"J Cell Physiol"},{"issue":"5","key":"888_CR18","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1517\/14728222.9.5.931","volume":"9","author":"A Togari","year":"2005","unstructured":"Togari A, Arai M, Kondo A. The role of the sympathetic nervous system in controlling bone metabolism. Expert Opin Ther Targets. 2005;9(5):931\u201340.","journal-title":"Expert Opin Ther Targets"},{"key":"888_CR19","doi-asserted-by":"crossref","unstructured":"Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, et al. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J. 2008;22(7):2465\u2013275.","DOI":"10.1096\/fj.07-098954"},{"key":"888_CR20","doi-asserted-by":"crossref","unstructured":"Nakagami H, Osako MK, Morishita R. Potential effect of angiotensin II receptor blockade in adipose tissue and bone. Curr Pharm Des. 2013;19(17):3049\u201353.","DOI":"10.2174\/1381612811319170011"},{"issue":"1\u20133","key":"888_CR21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejphar.2010.02.039","volume":"635","author":"K Ushijima","year":"2010","unstructured":"Ushijima K, Liu Y, Maekawa T, Ishikawa E, Motosugi Y, Ando H, et al. Protective effect of amlodipine against osteoporosis in stroke-prone spontaneously hypertensive rats. Eur J Pharmacol. 2010;635(1\u20133):227\u201330.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"888_CR22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3892\/etm.2014.1475","volume":"7","author":"B Wang","year":"2014","unstructured":"Wang B, Bi M, Zhu Z, Wu L, Wang J. Effects of the antihypertensive drug benidipine on osteoblast function in vitro. Exp Ther Med. 2014;7(3):649\u201353.","journal-title":"Exp Ther Med"},{"issue":"6","key":"888_CR23","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.2779","volume":"31","author":"S Zaheer","year":"2016","unstructured":"Zaheer S, de Boer I, Allison M, Brown JM, Psaty BM, Robinson-Cohen C, et al. Parathyroid hormone and the use of diuretics and Calcium-Channel blockers: the multi-ethnic study of atherosclerosis. J Bone Miner Res. 2016;31(6):1137\u201345.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"888_CR24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jamainternmed.2013.14764","volume":"174","author":"ME Tinetti","year":"2014","unstructured":"Tinetti ME, Han L, Lee DS, McAvay GJ, Peduzzi P, Gross CP, et al. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014;174(4):588\u201395.","journal-title":"JAMA Intern Med"},{"key":"888_CR25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/00365515909060464","volume":"11","author":"A Lamberg","year":"1959","unstructured":"Lamberg A, Kuhlback C. Effect of chlorothiazide and hydrochlorothiazide on the excretion of calcium in urine. Scand J Clin Lab Invest. 1959;11:351\u20137.","journal-title":"Scand J Clin Lab Invest"},{"key":"888_CR26","doi-asserted-by":"crossref","unstructured":"Transbol I, Christensen MS, Jensen GF, Christiansen C, McNair P. Thiazide for postponement of postmenopausal bone loss. Metabolism. 1982;31(4):383\u20136.","DOI":"10.1016\/0026-0495(82)90115-9"},{"key":"888_CR27","doi-asserted-by":"crossref","unstructured":"Wasnich RD, Benfante RJ, Yano K, Heilburn L, Vogel JM. Thiazide effect on the mineral content of bone. N Engl J Med. 1983;309(6):344\u20136.","DOI":"10.1056\/NEJM198308113090605"},{"key":"888_CR28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJM199002013220502","volume":"322","author":"AZ LaCroix","year":"1990","unstructured":"LaCroix AZ, Wienpahl J, White LR, et al. Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med. 1990;322:286\u201390.","journal-title":"N Engl J Med"},{"key":"888_CR29","doi-asserted-by":"crossref","unstructured":"Ray WA, Griffin MR, Downey W, Melton LJ. Long-term use of thiazide diuretics and risk of hip fracture. Lancet. 1989;1(8640):687\u201390.","DOI":"10.1016\/S0140-6736(89)92205-8"},{"issue":"3","key":"888_CR30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.1991.03460030076032","volume":"265","author":"DT Felson","year":"1991","unstructured":"Felson DT, Sloutskis D, Anderson JJ, Anthony JM, Kiel DP. Thiazide diuretics and the risk of hip fracture. Results from the Framingham study. JAMA. 1991;265(3):370\u20133.","journal-title":"JAMA"},{"issue":"4","key":"888_CR31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2796.2006.01695.x","volume":"260","author":"M Wiens","year":"2006","unstructured":"\u2022 Wiens M, Etminan M, Gill SS, Takkouche B. Effects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studies. J Intern Med. 2006;260(4):350\u201362. One of several meta-analyses of the association of fractures with antihypertensive medications.","journal-title":"J Intern Med"},{"issue":"7","key":"888_CR32","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/jbmr.356","volume":"26","author":"DH Solomon","year":"2011","unstructured":"\u2022 Solomon DH, Mogun H, Garneau K, Fischer MA. Risk of fractures in older adults using antihypertensive medications. J Bone Miner Res. 2011;26(7):1561\u20137. One of several meta-analyses of the association of fractures with antihypertensive medications.","journal-title":"J Bone Miner Res"},{"key":"888_CR33","doi-asserted-by":"publisher","unstructured":"\u2022 Aung K, Htay T. Thiazide diuretics and the risk of hip fracture. Cochrane Database Syst Rev. 2011 Oct 5;10(10):CD005185. doi: \n10.1002\/14651858.CD005185.pub2\n\n.One of several meta-analyses of the association of fractures with antihypertensive medications.","DOI":"10.1002\/14651858.CD005185.pub2"},{"issue":"1","key":"888_CR34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jamainternmed.2016.6821","volume":"177","author":"R Puttnam","year":"2017","unstructured":"\u2022\u2022 Puttnam R, Davis BR, Pressel SL, Whelton PK, Cushman WC, Louis GT, et al. Antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) collaborative research group. Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults: secondary analysis of a randomized clinical trial. JAMA Intern Med. 2017;177(1):67\u201376. The only randomized study to demonstrate that thiazide diuretics reduce the risk of hip and pelvic fractures as compared to other antihypertensive medications.","journal-title":"JAMA Intern Med"},{"issue":"9","key":"888_CR35","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1681\/ASN.2007030348","volume":"18","author":"MM Dvorak","year":"2007","unstructured":"Dvorak MM, De Joussineau C, Carter DH, Pisitkun T, Knepper MA, Gamba G, et al. Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone. J Am Soc Nephrol. 2007;18(9):2509\u201316.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"888_CR36","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.amjmed.2016.07.013","volume":"129","author":"JM Paik","year":"2016","unstructured":"Paik JM, Rosen HN, Gordon CM, Curhan GC. Diuretic use and risk of vertebral fracture in women. Am J Med. 2016;129(12):1299\u2013306.","journal-title":"Am J Med"},{"issue":"5","key":"888_CR37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0002-9343(00)00510-6","volume":"109","author":"IR Reid","year":"2000","unstructured":"Reid IR, Ames RW, Orr-Walker BJ, Clearwater JM, Horne AM, Evans MC, et al. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med. 2000;109(5):362\u201370.","journal-title":"Am J Med"},{"issue":"5","key":"888_CR38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ageing\/afq071","volume":"39","author":"R Peters","year":"2010","unstructured":"Peters R, Beckett N, Burch L, de Vernejoul MC, Liu L, Duggan J, et al. The effect of treatment based on a diuretic (indapamide) +\/\u2212 ACE inhibitor (perindopril) on fractures in the hypertension in the very elderly trial (HYVET). Age Ageing. 2010;39(5):609\u201316.","journal-title":"Age Ageing"},{"issue":"4 suppl","key":"888_CR39","first-page":"15","volume":"32","author":"R Caudarella","year":"2009","unstructured":"Caudarella R, Vescini F, Rizzoli E, Francucci CM. Salt intake, hypertension, and osteoporosis. J Endocrinol Investig. 2009;32(4 suppl):15\u201320.","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"888_CR40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.amjhyper.2004.08.016","volume":"18","author":"JL P\u00e9rez-Castrill\u00f3n","year":"2005","unstructured":"P\u00e9rez-Castrill\u00f3n JL, Mart\u00edn-Escudero JC, Alvarez Manzanares P, Cort\u00e9s Sancho R, Iglesias Zamora S, Garc\u00eda Alonso M. Hypertension as a risk factor for hip fracture. Am J Hypertens. 2005;18(1):146\u20137.","journal-title":"Am J Hypertens"},{"issue":"1","key":"888_CR41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/HJH.0000000000001124","volume":"35","author":"T Bokrantz","year":"2017","unstructured":"Bokrantz T, Ljungman C, Kahan T, Bostr\u00f6m KB, Hasselstr\u00f6m J, Hjerpe P, et al. Thiazide diuretics and the risk of osteoporotic fractures in hypertensive patients. Results from the Swedish primary care cardiovascular database. J Hypertens. 2017;35(1):188\u201397.","journal-title":"J Hypertens"},{"key":"888_CR42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12877-015-0154-5","volume":"15","author":"S Ruths","year":"2015","unstructured":"\u2022 Ruths S, Bakken MS, Ranhoff AH, Hunskaar S, Enges\u00e6ter LB, Engeland A. Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study. BMC Geriatr. 2015;15:153. doi:\n10.1186\/s12877-015-0154-5\n\n. The impact of antihypertensive medications on hip fracture risk. An observational study.","journal-title":"BMC Geriatr"},{"issue":"3","key":"888_CR43","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00198-015-3332-6","volume":"27","author":"DH Solomon","year":"2016","unstructured":"\u2022 Solomon DH, Ruppert K, Zhao Z, Lian YJ, Kuo IH, Greendale GA, et al. Bone mineral density changes among women initiating blood pressure lowering drugs: a SWAN cohort study. Osteoporos Int. 2016;27(3):1181\u20139. The impact of antihypertensive medications on hip fracture risk. An observational study.","journal-title":"Osteoporos Int"},{"issue":"1","key":"888_CR44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1359\/jbmr.0301214","volume":"19","author":"JA Pasco","year":"2004","unstructured":"Pasco JA, Henry MJ, Sanders KM, Kotowicz MA, Seeman E. Nicholson GC; Geelong osteoporosis study.Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong osteoporosis study. J Bone Miner Res. 2004;19(1):19\u201324.","journal-title":"J Bone Miner Res"},{"issue":"11","key":"888_CR45","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","volume":"292","author":"RG Schlienger","year":"2004","unstructured":"Schlienger RG, Kraenzlin ME, Jick SS, Meier CR. Use of beta-blockers and risk of fractures. JAMA. 2004;292(11):1326\u201332.","journal-title":"JAMA"},{"issue":"9","key":"888_CR46","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00198-007-0354-8","volume":"18","author":"C Meisinger","year":"2007","unstructured":"Meisinger C, Heier M, Lang O, D\u00f6ring A. Beta-blocker use and risk of fractures in men and women from the general population: the MONICA\/KORA Augsburg cohort study. Osteoporos Int. 2007;18(9):1189\u201395.","journal-title":"Osteoporos Int"},{"issue":"5","key":"888_CR47","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bone.2007.01.006","volume":"40","author":"N Bonnet","year":"2007","unstructured":"Bonnet N, Gadois C, McCloskey E, Lemineur G, Lespessailles E, Courteix D, et al. Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture. Bone. 2007;40(5):1209\u201316.","journal-title":"Bone"},{"issue":"5","key":"888_CR48","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.bone.2012.07.013","volume":"51","author":"S Yang","year":"2012","unstructured":"Yang S, Nguyen ND, Eisman JA, Nguyen TV. Association between beta-blockers and fracture risk: a Bayesian meta-analysis. Bone. 2012;51(5):969\u201374.","journal-title":"Bone"},{"issue":"6","key":"888_CR49","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bone.2012.08.126","volume":"51","author":"HJ Song","year":"2012","unstructured":"Song HJ, Lee J, Kim YJ, Jung SY, Kim HJ, Choi NK, et al. \u03b21 selectivity of \u03b2-blockers and reduced risk of fractures in elderly hypertension patients. Bone. 2012;51(6):1008\u201315.","journal-title":"Bone"},{"issue":"1","key":"888_CR50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00198-013-2498-z","volume":"25","author":"KA Toulis","year":"2014","unstructured":"Toulis KA, Hemming K, Stergianos S, Nirantharakumar K, Bilezikian JP. \u03b2-adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects. Osteoporos Int. 2014;25(1):121\u20139.","journal-title":"Osteoporos Int"},{"issue":"5","key":"888_CR51","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00223-004-0222-x","volume":"75","author":"L Rejnmark","year":"2004","unstructured":"Rejnmark L, Vestergaard P, Kassem M, Christoffersen BR, Kolthoff N, Brixen K, et al. Fracture risk in perimenopausal women treated with beta-blockers. Calcif Tissue Int. 2004;75(5):365\u201372.","journal-title":"Calcif Tissue Int"},{"key":"888_CR52","doi-asserted-by":"crossref","unstructured":"Reid IR, Gamble GD, Grey AB, Black DM, Ensrud KE, Browner WS, et al. Beta blocker use, BMD, and fractures in the study of osteoporotic fractures. J Bone Miner Res. 2005;20(4):613\u20138.","DOI":"10.1359\/JBMR.041202"},{"issue":"3","key":"888_CR53","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1532-5415.2005.53178_7.x","volume":"53","author":"R Levasseur","year":"2005","unstructured":"Levasseur R, Dargent-Molina P, Sabatier JP, Marcelli C, Br\u00e9art G. Beta-blocker use, bone mineral density, and fracture risk in older women: results from the Epidemiologie de l'Osteoporose prospective study. J Am Geriatr Soc. 2005;53(3):550\u20132.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"888_CR54","first-page":"105","volume":"8","author":"IR Reid","year":"2008","unstructured":"Reid IR. Effects of beta-blockers on fracture risk. J Musculoskelet Neuronal Interact. 2008;8(2):105\u201310.","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"9","key":"888_CR55","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1517\/13543784.17.9.1281","volume":"17","author":"S Graham","year":"2008","unstructured":"Graham S, Hammond-Jones D, Gamie Z, Polyzois I, Tsiridis E, Tsiridis E. The effect of beta-blockers on bone metabolism as potential drugs under investigation for osteoporosis and fracture healing. Expert Opin Investig Drugs. 2008;17(9):1281\u201399.","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"888_CR56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00774-012-0389-6","volume":"31","author":"S Takaoka","year":"2013","unstructured":"Takaoka S, Yamaguchi T, Tanaka K, Morita M, Yamamoto M, Yamauchi M, et al. Fracture risk is increased by the complication of hypertension and treatment with calcium channel blockers in postmenopausal women with type 2 diabetes. J Bone Miner Metab. 2013;31(1):102\u20137.","journal-title":"J Bone Miner Metab"},{"issue":"5","key":"888_CR57","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1590\/S0102-311X2002000500029","volume":"18","author":"S Coutinho Ed Eda","year":"2002","unstructured":"Coutinho Ed Eda S, Silva SD. Medication as a risk factor for falls resulting in severe fractures in the elderly [article in Portuguese]. Cad Saude Publica. 2002;18(5):1359\u201366.","journal-title":"Cad Saude Publica"},{"issue":"24","key":"888_CR58","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.4103\/0366-6999.195472","volume":"129","author":"HY Chen","year":"2016","unstructured":"Chen HY, Ma KY, Hsieh PL, Liou YS, Jong GP. Long-term effects of antihypertensive drug use and new-onset osteoporotic fracture in elderly patients: apopulation-based longitudinal cohort study. Chin Med J. 2016;129(24):2907\u201312.","journal-title":"Chin Med J"},{"issue":"3","key":"888_CR59","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","volume":"24","author":"L Rejnmark","year":"2006","unstructured":"\u2022 Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens. 2006;24(3):581\u20139. The impact of various antihypertensive medications on fracture risk. An observational study.","journal-title":"J Hypertens"},{"issue":"12","key":"888_CR60","doi-asserted-by":"publisher","first-page":"e009522","DOI":"10.1136\/bmjopen-2015-009522","volume":"5","author":"M Torstensson","year":"2015","unstructured":"\u2022 Torstensson M, Hansen AH, Leth-M\u00f8ller K, J\u00f8rgensen TS, Sahlberg M, Andersson C, et al. Danish register-based study on the association between specific cardiovascular drugs and fragility fractures. BMJ Open. 2015;5(12):e009522. doi:\n10.1136\/bmjopen-2015-009522\n\n. The impact of various antihypertensive medications on fracture risk. An observational study.","journal-title":"BMJ Open"},{"issue":"7","key":"888_CR61","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.3390\/ijms12074206","volume":"12","author":"XX Guan","year":"2011","unstructured":"Guan XX, Zhou Y, Li JY. Reciprocal roles of angiotensin II and angiotensin II receptors blockade (ARB) in regulating Cbfa1\/RANKL via cAMP signaling pathway: possible mechanism for hypertension-related osteoporosis and antagonistic effect of ARB on hypertension-related osteoporosis. Int J Mol Sci. 2011;12(7):4206\u201313.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"888_CR62","first-page":"57","volume":"46","author":"T Kwok","year":"2017","unstructured":"Kwok T, Leung J, Barrett-Connor E. For the osteoporotic fractures in men (MrOS) research group.ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men. Age Ageing. 2017;46(1):57\u201364.","journal-title":"Age Ageing"},{"issue":"11","key":"888_CR63","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/jbmr.2271","volume":"29","author":"DA Butt","year":"2014","unstructured":"\u2022 Butt DA, Mamdani M, Gomes T, Lix L, Lu H, Tu K. Hypertension outcome, surveillance team. Risk of osteoporotic fractures with angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in hypertensive community-dwelling elderly. J Bone Miner Res. 2014;29(11):2483\u20138.","journal-title":"J Bone Miner Res"},{"key":"888_CR64","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/joim.12446","volume":"278","author":"DA Butt","year":"2015","unstructured":"\u2022\u2022 Butt DA, Harvey PJ. Benefits and risks of antihypertensive medications in the elderly. J Intern Med. 2015;278:599\u2013626. A thorough review and discussion of the effects of antihypertensive medications on falls and fractures.","journal-title":"J Intern Med"},{"issue":"12","key":"888_CR65","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s11606-014-2961-3","volume":"29","author":"KL Margolis","year":"2014","unstructured":"Margolis KL, Palermo L, Vittinghoff E, Evans GW, Atkinson HH, Hamilton BP, et al. Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial. J Gen Intern Med. 2014;29(12):1599\u2013606.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"888_CR66","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/HYPERTENSIONAHA.115.05513","volume":"66","author":"LA Lipsitz","year":"2015","unstructured":"Lipsitz LA, Habtemariam D, Gagnon M, Iloputaife I, Sorond F, Tchalla AE, et al. Reexamining the effect of antihypertensive medications on falls in old age. Hypertension. 2015;66(1):183\u20139.","journal-title":"Hypertension"},{"issue":"3","key":"888_CR67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jamda.2015.08.022","volume":"17","author":"S Jansen","year":"2016","unstructured":"Jansen S, Bhangu J, de Rooij S, Daams J, Kenny RA, van der Velde N. The Association of Cardiovascular disorders and falls: asystematic review. J Am Med Dir Assoc. 2016;17(3):193\u20139.","journal-title":"J Am Med Dir Assoc"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-017-0888-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-017-0888-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-017-0888-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T08:59:12Z","timestamp":1504169952000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-017-0888-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["888"],"URL":"https:\/\/doi.org\/10.1007\/s11886-017-0888-0","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]},"article-number":"76"}}